Results 61 to 70 of about 11,397 (98)

Lysine-specific histone demethylase 1 (LSD1) [PDF]

Science-Business eXchange, 2009
openaire   +2 more sources

Identification of epigenetic monotherapy candidates in taxane-resistant CRPC. [PDF]

Turk J Biol
Cevatemre B, Bulut İ, Karyemez E, Açilan C.   +3 more
europepmc   +1 more source

Lysine-specific demethylase 1 regulates hematopoietic stem cell expansion and myeloid cell differentiation. [PDF]

Cell Death Dis
Staehle HF, Koellerer C, Staehle AM, Schulze J, Eble P, Müller A, Zell F, Müller JM, Perner F, Attia A, Mallm JP, Pozdnyakova O, Rippe K, Brors B, Feuerbach L, Imbusch CD, Metzger E, Schüle R, Pahl HL, Jutzi JS.   +19 more
europepmc   +1 more source

Histone-modifying enzymes as drivers and therapeutic targets in androgen-resistant prostate cancer. [PDF]

Front Endocrinol (Lausanne)
Purohit TA, Bahr K, Yang B, Schultz Z, Lewis PW, Denu JM, Jarrard DF.   +6 more
europepmc   +1 more source

Cytochrome b5 reductase orchestrates IL-1β production in macrophages through FAD. [PDF]

Cell Death Dis
Fu J, Liu Z, Zhang H, Zhang X, Liu S, Mei X, Zeng X, Ren W.   +7 more
europepmc   +1 more source

The Targeted Inhibition of Histone Lysine Demethylases as a Novel Promising Anti-Cancer Therapeutic Strategy-An Update on Recent Evidence. [PDF]

Cancers (Basel)
Paluszczak J, Kleszcz R.
europepmc   +1 more source

Synthetic and structure-activity studies of SP2577 and TCP towards LSD1 targeting PROTACs. [PDF]

RSC Med Chem
Coulson ME, Norris JKS, Smith SA, Smalley JP, Schwabe JWR, Cowley SM, Hodgkinson JT.   +6 more
europepmc   +1 more source

From mutation to medication: iadademstat and the next era in MDS targeted therapy. [PDF]

Ann Med Surg (Lond)
Zabeehullah F, Mayo JZ, Tariq A, Abdullah F, Hameed MF, Ahmad MH, Saeed H.   +6 more
europepmc   +1 more source

Histone demethylase LSD1 regulates lipid homeostasis during <i>Cryptococcus neoformans</i> infection. [PDF]

iScience
Lohia GK, Shah A, Balaji KN.
europepmc   +1 more source